Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326390 · ClinicalTrials.gov registry record
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT01326390: Clinical Trial study, sponsored by Stanford University.
NCT01326390 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01326390 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.
Interventions
- DEVICE dTA/dBA C-arm fluoroscopy system with Dyna CT
- PROCEDURE DSA arteriogram- hepatic arteries
- PROCEDURE CO2 aortogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-01 |
Why NCT01326390 stopped before completion
NCT01326390 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which dTA/dBA C-arm fluoroscopy system with Dyna CT is the first listed.
NCT01326390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01326390 about?
NCT01326390 is a clinical study titled "Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma". Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.
What is the current status of trial NCT01326390?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2010-05. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01326390?
The interventions under investigation include: dTA/dBA C-arm fluoroscopy system with Dyna CT (DEVICE), DSA arteriogram- hepatic arteries (PROCEDURE), CO2 aortogram (PROCEDURE).
Who is sponsoring clinical trial NCT01326390?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia